Purcell International

About Purcell International

Purcell develops reusable, smart inhalers that are medication-agnostic and designed with a patient-centric approach. These inhalers enhance medication adherence and provide real-time data to improve respiratory health management.

```xml <problem> Many individuals with respiratory conditions struggle with medication adherence due to the complexities of using traditional inhalers and the lack of real-time feedback on their usage. This can lead to poorly managed symptoms and increased healthcare costs. </problem> <solution> Purcell offers reusable, medication-agnostic smart inhalers designed to improve patient adherence and respiratory health management. These inhalers provide real-time data on medication usage, allowing patients and healthcare providers to track adherence and identify potential issues. By combining user-friendly design with advanced sensor technology, Purcell empowers individuals to take control of their respiratory health and optimize their treatment plans. The inhalers are compatible with a variety of medications, making them a versatile solution for different respiratory conditions. </solution> <features> - Reusable design reduces environmental impact and lowers long-term costs. - Medication-agnostic compatibility allows use with various prescribed inhalers. - Integrated sensors track inhaler usage, including dose timing and technique. - Real-time feedback via a connected mobile app helps users improve their inhalation technique. - Data analytics platform provides insights into patient adherence patterns for healthcare providers. </features> <target_audience> Purcell's primary target audience includes individuals with asthma, COPD, and other respiratory conditions, as well as healthcare providers and respiratory therapists who manage these patients. </target_audience> ```

What does Purcell International do?

Purcell develops reusable, smart inhalers that are medication-agnostic and designed with a patient-centric approach. These inhalers enhance medication adherence and provide real-time data to improve respiratory health management.

Where is Purcell International located?

Purcell International is based in London, United Kingdom.

When was Purcell International founded?

Purcell International was founded in 2020.

Location
London, United Kingdom
Founded
2020
Employees
24 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

Purcell International

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

Purcell develops reusable, smart inhalers that are medication-agnostic and designed with a patient-centric approach. These inhalers enhance medication adherence and provide real-time data to improve respiratory health management.

purcell.ai700+
Founded 2020London, United Kingdom

Funding

No funding information available.

Team (20+)

No team information available.

Company Description

Problem

Many individuals with respiratory conditions struggle with medication adherence due to the complexities of using traditional inhalers and the lack of real-time feedback on their usage. This can lead to poorly managed symptoms and increased healthcare costs.

Solution

Purcell offers reusable, medication-agnostic smart inhalers designed to improve patient adherence and respiratory health management. These inhalers provide real-time data on medication usage, allowing patients and healthcare providers to track adherence and identify potential issues. By combining user-friendly design with advanced sensor technology, Purcell empowers individuals to take control of their respiratory health and optimize their treatment plans. The inhalers are compatible with a variety of medications, making them a versatile solution for different respiratory conditions.

Features

Reusable design reduces environmental impact and lowers long-term costs.

Medication-agnostic compatibility allows use with various prescribed inhalers.

Integrated sensors track inhaler usage, including dose timing and technique.

Real-time feedback via a connected mobile app helps users improve their inhalation technique.

Data analytics platform provides insights into patient adherence patterns for healthcare providers.

Target Audience

Purcell's primary target audience includes individuals with asthma, COPD, and other respiratory conditions, as well as healthcare providers and respiratory therapists who manage these patients.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.